Mild Traumatic Brain Injury, ConcussionNCT07466589
Advancement of Vestibular Intervention Via Portable Electrical Stimulator (VIPES)
A study testing Stochastic Galvanic Vestibular Stimulation (sGVS) in people with Mild Traumatic Brain Injury, Concussion, run by Vivonics, Inc. at 1 site in United States.
Trial summary
The goal is to assess the potential benefit of stochastic galvanic vestibular stimulation (sGVS) in improving patient performance with respect to balance, gait, and/or overall vestibular function for individuals with known deficits in vestibular performance as a result of a mild traumatic brain injury (mTBI). Read more about this study
- Who is it for?
- Ages 18 to 55 years
- Conditions the study is for
- Mild Traumatic Brain Injury, Concussion
- What is being tested?
- Stochastic Galvanic Vestibular Stimulation (sGVS)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- 1 siteUnited States
- Study dates
- 22 Aug 2025to Mar 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Age 18-55
- Diagnosed with concussion, evaluated at the University of Michigan
- Symptoms persistent greater than 4-6 weeks
- Self-reported imbalance
- Must be able to attend in-person session.
- No racial/ethnic groups will be excluded, although all participants must be fluent speakers of English.
Who cannot join
- Anyone under the age of 18 or over the age of 55
- Presence of prior diagnosis of peripheral vestibulopathy
- Women who are pregnant
- Inability to complete testing (e.g., severe symptom burden, inability to stand unassisted).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Michigan, Michigan Medicine
Ann Arbor, Michigan, 48109
Deb Demski, MUP, MSW, CCRP, 734-647-2147, darfy@med.umich.edu
Matthew Morley, MA, 734-647-3326, morleymm@umich.edu
About this study
The goal is to assess the potential benefit of stochastic galvanic vestibular stimulation (sGVS) in improving patient performance with respect to balance, gait, and/or overall vestibular function for individuals with known deficits in vestibular performance as a result of a mild traumatic brain injury (mTBI).
Read the detailed description
The VIPES system that delivers sGVS is a small wearable device that administers stimulation aiming to improve the function of a vestibular system that has been adversely affected by mild TBI, concussion. In particular VIPES is designed to provide stimulus comprising random noise in a low frequency band (0 to 5Hz maximum) below the level of perception by the subject. The VIPES system consists of the four electrodes (two behind each ear). The stimulator can deliver the stimulation in multiple directions and receive information about the amplitude delivered accounting for skin impedance. The Bertec Portable Essential's dual-balance plate balance system and the APDM Opal V2R sensor are used as reference measurement tools for assessing clinical performance.
The study to be completed is an N=32 single-arm clinical investigation, comprised of a within-subject crossover study designed to evaluate whether electrical stimulation delivered by a wearable vestibular system can improve functional performance on clinical balance and mobility assessments. All participants will complete both Timed Up and Go (TUG) and mCTSIB + COBALT performance tests under a series of stimulation conditions.
Each test session begins with a Baseline (no stimulation) trial, followed by four additional trials under different stimulation levels: 0mA (sham), 0.33mA, 0.67mA, and 1.0mA. The stimulation sequence is randomized after Baseline. Participants are blinded to stimulation level during all trials.
Participants will be recruited from the pool of patients treated at the University of Michigan - NeuroSport Clinic for mTBI. Upon passing pre-screening through chart review and via phone, interested individuals will be scheduled for a study visit that begins with obtained informed consent. Prior to beginning the testing procedures, enrolled participants will provide demographic information (age, sex/gender, race, ethnicity), have height measured, weight measured, and provide a detailed medical history, history of present illness, a list of current medications, as well as complete a post-concussion symptoms questionnaire.
The performance tests to be completed:
- Modified Clinical Test of Sensory Integration on Balance (mCTSIB): Tool: Bertec Portable Essential's dual-balance plate balance system Rationale: mCTSIB is a balance test commonly used to evaluate individuals of all ages post-concussion. This test protocol assesses how well an individual uses sensory input when one or more sensory systems are compromised. This protocol is commonly used to evaluate individuals post-concussion to describe static balance ability. The test will be performed for each sGVS amplitudes from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments. Two trials for each of the following conditions:
- Standard (eyes open on firm surface)
- Proprioception (eyes closed on firm surface)
- Vision (eyes open on foam surface)
- Vestibular (eye closed on foam surface)
- COBALT Balance Test: Tool: Bertec Portable Essential's dual-balance plate balance system Rationale: COBALT is a balance test commonly used to evaluate individuals post-concussion. This test protocol places high demand on the visual and vestibular systems that is not provided by traditional balance tests. These higher demand conditions improve sensitivity in detecting balance dysfunction in those post-concussion. The test will be performed for each sGVS currents from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments. Two trials for each of the following conditions/surfaces: On Firm Surface:
- Head Shake - Standing on firm surface with feet apart, head movement*
- Normal stance with headshake and eyes closed. The subject will be instructed to stand still, with hands on hips and then asked to adjust head positioning approximately 30 degrees from a center position in sync with a metronome set at 120 beats/min.
- Participant will practice with eyes open and when ready close eyes.
- Visual Motion Sensitivity - Visual motion sensitivity condition on firm surface.
- The subject is instructed to stand at the center of the balance plate with feet together and both arms extended out in front with hands clasped together and the thumbs straight up. The subject is to focus on the thumbs held in front while rotating approximately 30 degrees right and left, for a total excursion of 60 degrees, in sync with the metronome set at 40 beats/min. On Foam Surface:
- Head Shake - Standing on foam with feet apart, head movement*
- Normal stance with head shake and eyes closed on foam. Performed with the foam pad placed on the balance plate with the same procedure and parameters as HS on firm surface described above.
- Visual Motion Sensitivity - Visual motion sensitivity condition on foam. o Performed with the foam pad placed on the balance plate with the same procedure and parameters as VMS condition on firm surface described above.
- Timed up and go (TUG):
Tool: Opal V2R Sensor
Rationale: TUG is a test used to assess an individual's functional balance. It requires appropriate static and dynamic balance system integration. TUG provides a measure of functional balance integration not provided from standing balance tasks.
The test will be performed for each GVS amplitudes from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments.
- The subject starts in a seated position
- The subject stands up upon research staff command: walks 3 meters, turns around, walks back to the chair and sits down.
- The time stops when the patient is seated.
Participants take a break following the testing prior to repeating. Following completion of the study, participants are asked to completed a short System Usability Scale Questionnaire. The entire study visit is estimated to take about 120 minutes.
The overall aim of the study is to determine whether performance improves under active stimulation conditions when compared to sham trials. Results may inform optimal parameter selection for future efficacy-focused studies.
- Conditions
- Mild Traumatic Brain Injury, Concussion
- Being tested
- Stochastic Galvanic Vestibular Stimulation (sGVS)
- Keywords
- mTBI, mild traumatic brain injury, concussion, balance, gait, vestibular, GVS
- Medical subject headings
- Brain Concussion
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Stochastic Galvanic Vestibular Stimulation (sGVS)Device
The investigational intervention is a non-invasive, wearable vestibular stimulation system that delivers subsensory electrical stimulation via surface electrodes behind the ears. Stimulation is delivered at one of four levels (0.33mA, 0.67mA, 1.0mA, and 0mA sham) during standard clinical balance and mobility assessments (TUG and BERTEC). Participants are blinded to stimulation level during each trial.
| Study group | Role | What they receive |
|---|---|---|
| All Participants: Randomized Stimulation Sequence | Experimental | All participants complete all performance test types (TUG and mCTSIB + COBALT), and complete each performance test under all stimulation levels (Baseline + 0mA + 0.33mA + 0.67mA + 1.0mA). Test order and stimulation sequence are randomized. Receives: Device: Stochastic Galvanic Vestibular Stimulation (sGVS) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Postural Sway during mCTSIB Across Stimulation Conditions
Comparison of sway area (deg/s) during mCTSIB at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).
Measured: Performance assessed when VIPES is worn and patient is completing the testing procedure.
Change in TUG Time to Completion
Comparison of time to complete the Timed Up and Go (TUG) test (seconds) at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).
Measured: Performance assessed when VIPES is worn and patient is completing the testing procedure.
Change in Postural Sway during COBALT
Comparison of sway area (deg/s) during COBALT at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).
Measured: Performance assessed when VIPES is worn and patient is completing the testing procedures
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Mar 2026
- Study start22 Aug 2025
- Primary completionMar 2026 (estimated)
- Study completionMar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mild Traumatic Brain Injury, ConcussionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Crossover
- Model description
- This study uses a within-subject, crossover assignment model in which all participants experience every condition. Each subject completes testing procedures at randomized stimulation levels during testing. The subjects will complete the testing procedures TUG, mCTSIB, and COBALT, at at four randomized stimulation levels: 0mA (SHAM), 0.33mA, 0.67mA, and 1.0mA. Given this study is a repeated measures study, each subject will complete a trial of a given testing procedure at a certain stimulation level twice, and continue to do so for all other testing procedures and stimulation levels. The design allows for within-subject comparisons to randomized sham controls, across stimulation intensities in effort to enhancing sensitivity in detecting changes in performance.
- Masking
- None (open label)
- Enrolment
- 32 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Vivonics, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- University of Michigan
- Responsible party
- Sponsor
- Investigators
- Devin L McCaslin, PhD, Principal investigator, University of Michigan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07466589
- Sponsor's protocol ID
- HUM00257686
- Other IDs
- HT942524C0022
- Status last verified
- Mar 2026
- First submitted
- 8 Sep 2025
- Last updated
- 12 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Advancement of Vestibular Intervention Via Portable Electrical Stimulator (VIPES)
- ClinicalTrials.gov ID
- NCT07466589
- Acronym / sponsor ID
- HUM00257686
- Conditions
- Mild Traumatic Brain Injury, Concussion
- Keywords
- mTBI, mild traumatic brain injury, concussion, balance, gait, vestibular, GVS
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 32 participants (estimated)
- Lead sponsor
- Vivonics, Inc.Industry (pharma, biotech, devices)
- Collaborators
- University of Michigan
- Study start
- 22 Aug 2025 (actual)
- Primary completion
- Mar 2026 (estimated)
- Study completion
- Mar 2026 (estimated)
- First posted
- 12 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal is to assess the potential benefit of stochastic galvanic vestibular stimulation (sGVS) in improving patient performance with respect to balance, gait, and/or overall vestibular function for individuals with known deficits in vestibular performance as a result of a mild traumatic brain injury (mTBI).
Detailed description
The VIPES system that delivers sGVS is a small wearable device that administers stimulation aiming to improve the function of a vestibular system that has been adversely affected by mild TBI, concussion. In particular VIPES is designed to provide stimulus comprising random noise in a low frequency band (0 to 5Hz maximum) below the level of perception by the subject. The VIPES system consists of the four electrodes (two behind each ear). The stimulator can deliver the stimulation in multiple directions and receive information about the amplitude delivered accounting for skin impedance. The Bertec Portable Essential's dual-balance plate balance system and the APDM Opal V2R sensor are used as reference measurement tools for assessing clinical performance.
The study to be completed is an N=32 single-arm clinical investigation, comprised of a within-subject crossover study designed to evaluate whether electrical stimulation delivered by a wearable vestibular system can improve functional performance on clinical balance and mobility assessments. All participants will complete both Timed Up and Go (TUG) and mCTSIB + COBALT performance tests under a series of stimulation conditions.
Each test session begins with a Baseline (no stimulation) trial, followed by four additional trials under different stimulation levels: 0mA (sham), 0.33mA, 0.67mA, and 1.0mA. The stimulation sequence is randomized after Baseline. Participants are blinded to stimulation level during all trials.
Participants will be recruited from the pool of patients treated at the University of Michigan - NeuroSport Clinic for mTBI. Upon passing pre-screening through chart review and via phone, interested individuals will be scheduled for a study visit that begins with obtained informed consent. Prior to beginning the testing procedures, enrolled participants will provide demographic information (age, sex/gender, race, ethnicity), have height measured, weight measured, and provide a detailed medical history, history of present illness, a list of current medications, as well as complete a post-concussion symptoms questionnaire.
The performance tests to be completed:
- Modified Clinical Test of Sensory Integration on Balance (mCTSIB): Tool: Bertec Portable Essential's dual-balance plate balance system Rationale: mCTSIB is a balance test commonly used to evaluate individuals of all ages post-concussion. This test protocol assesses how well an individual uses sensory input when one or more sensory systems are compromised. This protocol is commonly used to evaluate individuals post-concussion to describe static balance ability. The test will be performed for each sGVS amplitudes from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments. Two trials for each of the following conditions:
- Standard (eyes open on firm surface)
- Proprioception (eyes closed on firm surface)
- Vision (eyes open on foam surface)
- Vestibular (eye closed on foam surface)
- COBALT Balance Test: Tool: Bertec Portable Essential's dual-balance plate balance system Rationale: COBALT is a balance test commonly used to evaluate individuals post-concussion. This test protocol places high demand on the visual and vestibular systems that is not provided by traditional balance tests. These higher demand conditions improve sensitivity in detecting balance dysfunction in those post-concussion. The test will be performed for each sGVS currents from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments. Two trials for each of the following conditions/surfaces: On Firm Surface:
- Head Shake - Standing on firm surface with feet apart, head movement*
- Normal stance with headshake and eyes closed. The subject will be instructed to stand still, with hands on hips and then asked to adjust head positioning approximately 30 degrees from a center position in sync with a metronome set at 120 beats/min.
- Participant will practice with eyes open and when ready close eyes.
- Visual Motion Sensitivity - Visual motion sensitivity condition on firm surface.
- The subject is instructed to stand at the center of the balance plate with feet together and both arms extended out in front with hands clasped together and the thumbs straight up. The subject is to focus on the thumbs held in front while rotating approximately 30 degrees right and left, for a total excursion of 60 degrees, in sync with the metronome set at 40 beats/min. On Foam Surface:
- Head Shake - Standing on foam with feet apart, head movement*
- Normal stance with head shake and eyes closed on foam. Performed with the foam pad placed on the balance plate with the same procedure and parameters as HS on firm surface described above.
- Visual Motion Sensitivity - Visual motion sensitivity condition on foam. o Performed with the foam pad placed on the balance plate with the same procedure and parameters as VMS condition on firm surface described above.
- Timed up and go (TUG):
Tool: Opal V2R Sensor
Rationale: TUG is a test used to assess an individual's functional balance. It requires appropriate static and dynamic balance system integration. TUG provides a measure of functional balance integration not provided from standing balance tasks.
The test will be performed for each GVS amplitudes from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments.
- The subject starts in a seated position
- The subject stands up upon research staff command: walks 3 meters, turns around, walks back to the chair and sits down.
- The time stops when the patient is seated.
Participants take a break following the testing prior to repeating. Following completion of the study, participants are asked to completed a short System Usability Scale Questionnaire. The entire study visit is estimated to take about 120 minutes.
The overall aim of the study is to determine whether performance improves under active stimulation conditions when compared to sham trials. Results may inform optimal parameter selection for future efficacy-focused studies.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- This study uses a within-subject, crossover assignment model in which all participants experience every condition. Each subject completes testing procedures at randomized stimulation levels during testing. The subjects will complete the testing procedures TUG, mCTSIB, and COBALT, at at four randomized stimulation levels: 0mA (SHAM), 0.33mA, 0.67mA, and 1.0mA. Given this study is a repeated measures study, each subject will complete a trial of a given testing procedure at a certain stimulation level twice, and continue to do so for all other testing procedures and stimulation levels. The design allows for within-subject comparisons to randomized sham controls, across stimulation intensities in effort to enhancing sensitivity in detecting changes in performance.
| Arm | Type | Receives |
|---|---|---|
| All Participants: Randomized Stimulation Sequence | Experimental | Device: Stochastic Galvanic Vestibular Stimulation (sGVS)All participants complete all performance test types (TUG and mCTSIB + COBALT), and complete each performance test under all stimulation levels (Baseline + 0mA + 0.33mA + 0.67mA + 1.0mA). Test order and stimulation sequence are randomized. |
Who may qualify
- Ages
- 18 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Age 18-55
- Diagnosed with concussion, evaluated at the University of Michigan
- Symptoms persistent greater than 4-6 weeks
- Self-reported imbalance
- Must be able to attend in-person session.
Key exclusion criteria (4 listed)
- Anyone under the age of 18 or over the age of 55
- Presence of prior diagnosis of peripheral vestibulopathy
- Women who are pregnant
- Inability to complete testing (e.g., severe symptom burden, inability to stand unassisted).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Stochastic Galvanic Vestibular Stimulation (sGVS)The investigational intervention is a non-invasive, wearable vestibular stimulation system that delivers subsensory electrical stimulation via surface electrodes behind the ears. Stimulation is delivered at one of four levels (0.33mA, 0.67mA, 1.0mA, and 0mA sham) during standard clinical balance and mobility assessments (TUG and BERTEC). Participants are blinded to stimulation level during each trial. | Device | All Participants: Randomized Stimulation Sequence |
Primary outcome
Change in Postural Sway during mCTSIB Across Stimulation Conditions
Time frame: Performance assessed when VIPES is worn and patient is completing the testing procedure.
Comparison of sway area (deg/s) during mCTSIB at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).
Change in TUG Time to Completion
Time frame: Performance assessed when VIPES is worn and patient is completing the testing procedure.
Comparison of time to complete the Timed Up and Go (TUG) test (seconds) at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).
Change in Postural Sway during COBALT
Time frame: Performance assessed when VIPES is worn and patient is completing the testing procedures
Comparison of sway area (deg/s) during COBALT at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Mild Traumatic Brain Injury, Concussion
Enrolling by invitationPhase 1
Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury
Mild Traumatic Brain Injury
Recruiting
Evaluation of Cognitive Behavioral Therapy for Insomnia (CBT-I) in Individuals With Mild Traumatic Brain Injury (mTBI)
Sleep Architecture, Mild Traumatic Brain Injury
Active, not recruiting
Pilot TMS in Mild TBI
Persistent Post Concussive Headache, Mild Traumatic Brain Injury
Recruiting
Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline
Mild Traumatic Brain Injury, Post Concussion Syndrome
Enrolling by invitation
Improving In-hospital and Post-discharge Patient Education for Mild Traumatic Brain Injury
Concussion, Mild, Traumatic Brain Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Devin L McCaslin, PhD principal investigator
University of Michigan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Stochastic Galvanic Vestibular Stimulation (sGVS) in people with Mild Traumatic Brain Injury, Concussion, run by Vivonics, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 12 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Joshua Colls, B.S. (781-373-1930 ext. 263, jcolls@vivonics.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Postural Sway during mCTSIB Across Stimulation Conditions (time frame: Performance assessed when VIPES is worn and patient is completing the testing procedure.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2026.